CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	3 Months Ended		6 Months Ended
	Jun. 29, 2013	Jun. 30, 2012	Jun. 29, 2013	Jun. 30, 2012
Net revenues:
Net commercial product revenues	$ 555,000	$ 529,000	$ 1,331,000	$ 873,000
Government and other contract revenues		67,000		122,000
Total net revenues	555,000	596,000	1,331,000	995,000
Costs and expenses:
Cost of commercial product revenues	394,000	1,078,000	620,000	1,922,000
Cost of government and other contract revenue		43,000		95,000
Research and development	1,411,000	1,314,000	2,849,000	2,475,000
Selling, general and administrative	1,130,000	1,604,000	2,475,000	2,952,000
Total costs and expenses	2,935,000	4,039,000	5,944,000	7,444,000
Loss from operations	(2,380,000)	(3,443,000)	(4,613,000)	(6,449,000)
Other Income and Expense:
Loss from investment in Resonant LLC joint venture	(56,000)		(238,000)
Other income		21,000	6,000	37,000
Interest income		3,000	1,000	5,000
Net loss	$ (2,436,000)	$ (3,419,000)	$ (4,844,000)	$ (6,407,000)
Basic and diluted loss per common share	$ (0.54)	$ (1.03)	$ (1.12)	$ (2.04)
Basic and diluted weighted average number of common shares outstanding	4,521,731	3,325,383	4,337,905	3,145,097